Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (701-710 of 715) with videos related to

Pageof 72
Sort By:
Journal of Thrombosis and Haemostasis : JTH|May 13, 2006
Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibodyM Jacquemin, C M Radcliffe, R Lavend'homme, et al.
Nature|January 20, 1983
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliD Pennica, W E Holmes, W J Kohr, et al.
Nature|December 31, 1997
Mice lacking factor VII develop normally but suffer fatal perinatal bleedingE D Rosen, J C Chan, E Idusogie, et al.
Nature Medicine|September 5, 2001
Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndromeD Nuyens, M Stengl, S Dugarmaa, et al.
Nature|August 11, 1998
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesisP Carmeliet, Y Dor, J M Herbert, et al.
Bulletin Du Cancer|January 7, 2005
[Prostate cancer diagnosed before 55: a retrospective study from the Rare Cancer Network]Tan Dat Nguyen, Philip M P Poortmans, Marleen van der Hulst, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2005
The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective studyTan Dat Nguyen, Philip M P Poortmans, Marleen van der Hulst, et al.
American Heart Journal|February 7, 1998
Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II TrialR P Tracy, N S Kleiman, B Thompson, et al.
The Journal of Cell Biology|March 27, 2001
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategiesK Bajou, V Masson, R D Gerard, et al.
Nature Medicine|May 6, 1999
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188P Carmeliet, Y S Ng, D Nuyens, et al.
Pageof 72

Showing results (701-710 of 715) with videos related to

Sort By:
Pageof 72
Journal of Thrombosis and Haemostasis : JTH|May 13, 2006
Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibodyM Jacquemin, C M Radcliffe, R Lavend'homme, et al.
Nature|January 20, 1983
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliD Pennica, W E Holmes, W J Kohr, et al.
Nature|December 31, 1997
Mice lacking factor VII develop normally but suffer fatal perinatal bleedingE D Rosen, J C Chan, E Idusogie, et al.
Nature Medicine|September 5, 2001
Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndromeD Nuyens, M Stengl, S Dugarmaa, et al.
Nature|August 11, 1998
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesisP Carmeliet, Y Dor, J M Herbert, et al.
Bulletin Du Cancer|January 7, 2005
[Prostate cancer diagnosed before 55: a retrospective study from the Rare Cancer Network]Tan Dat Nguyen, Philip M P Poortmans, Marleen van der Hulst, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2005
The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective studyTan Dat Nguyen, Philip M P Poortmans, Marleen van der Hulst, et al.
American Heart Journal|February 7, 1998
Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II TrialR P Tracy, N S Kleiman, B Thompson, et al.
The Journal of Cell Biology|March 27, 2001
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategiesK Bajou, V Masson, R D Gerard, et al.
Nature Medicine|May 6, 1999
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188P Carmeliet, Y S Ng, D Nuyens, et al.
Pageof 72